Harvey Wilfred Austin, MD | |
186 Jerry Browne Rd Unit 1204, Mystic, CT 06355-4006 | |
(703) 798-2290 | |
Not Available |
Full Name | Harvey Wilfred Austin |
---|---|
Gender | Male |
Speciality | Plastic Surgery - Plastic Surgery Within The Head And Neck |
Location | 186 Jerry Browne Rd Unit 1204, Mystic, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477140929 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2082S0099X | Plastic Surgery - Plastic Surgery Within The Head And Neck | 66903 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Harvey Wilfred Austin, MD 186 Jerry Browne Rd Unit 1204, Mystic, CT 06355-4006 Ph: (703) 798-2290 | Harvey Wilfred Austin, MD 186 Jerry Browne Rd Unit 1204, Mystic, CT 06355-4006 Ph: (703) 798-2290 |
News Archive
A Ā£3 million interdisciplinary research project is to address the growing threat of drug-resistant infections in India. The project will develop innovative diagnostics to curb antimicrobial resistance (AMR), one of the biggest threats to global public health.
Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, today announced the release of Therapeutic Area Essentialsā¢, a comprehensive suite of more than 155 therapeutic area e-courses covering diagnosis, cause, and treatment for over 40 disease states.
In chronic kidney disease patients, different levels of anemia treatment have a beneficial effect on the heart and improve quality of life, according to a pair of studies appearing in the April 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN).
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of suggested guidelines on establishing research partnerships with patients.
The Bush administration will oppose any attempts by congressional Democrats to pass legislation that would authorize the government to negotiate with pharmaceutical companies under the Medicare prescription drug benefit, according to HHS Secretary Mike Leavitt, the New York Times reports.
› Verified 7 days ago